Ying Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ying Liu has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
- Ian David Hickson
University of Copenhagen
20 shared publications Ian D. Hickson
Center for Chromosome Stability, Department of Cellular and Molecular Medicine, University of Copenhagen, 2200 Copenhagen N, Denmark
8 shared publications- Walter Fred Bodmer
Department of Oncology, University of Oxford
6 shared publications Wei Wu
Center for Chromosome Stability, Department of Cellular and Molecular Medicine, University of Copenhagen, 2200 Copenhagen N, Denmark
5 shared publicationsLiqun Ren
Center for Chromosome Stability, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark
4 shared publicationsRahul Bhowmick
Center for Chromosome Stability and Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Panum Institute, Blegdamsvej 3B, 2200 Copenhagen N, Denmark; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
4 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Springer Nature in Cell Death & Differentiation
- p. 1-20
DDX3X regulates DNA repair pathway choice at double-strand breaks via RNA-DNA hybrid formation
DNA Double-strand breaks (DSBs) are amongst the most cytotoxic DNA lesions. During the processing of DSBs, so-called Break-Induced RNA-DNA Hybrids (BIRDHs) are generated to promote timely DSB repair. Here, we identify the DEAD-box helicase DDX3X as a positive regulator of BIRDHs and a key factor in facilitating DSB repair via homologous recombination (HR). We demonstrate that DDX3X promotes BIRDH formation by inhibiting CST (CTC1, STN1, TEN1)-Polα fill-in synthesis, through limiting 53BP1 accumulation at DSBs in a Drosha-dependent manner. Notably, depletion of DDX3X impairs both BIRDH and BRCA1 focus formation, while disabling CST-Polα mediated fill-in synthesis in DDX3X-deficient cells restores these events. This suggests a competitive interplay between BIRDH formation and fill-in synthesis that influences DNA repair pathway choice. Consistent with a role in HR, DDX3X depletion sensitizes tumor cells to cisplatin in vitro and in vivo. We conclude that DDX3X promotes genome maintenance and cell viability following DSB formation through regulation of BIRDHs.
- 25 September 2026
- Published by Springer Nature in Cell Death & Differentiation
- p. 1-20
Open AccessDDX3X regulates DNA repair pathway choice at double-strand breaks via RNA-DNA hybrid formation
DNA Double-strand breaks (DSBs) are amongst the most cytotoxic DNA lesions. During the processing of DSBs, so-called Break-Induced RNA-DNA Hybrids (BIRDHs) are generated to promote timely DSB repair. Here, we identify the DEAD-box helicase DDX3X as a positive regulator of BIRDHs and a key factor in facilitating DSB repair via homologous recombination (HR). We demonstrate that DDX3X promotes BIRDH formation by inhibiting CST (CTC1, STN1, TEN1)-Polα fill-in synthesis, through limiting 53BP1 accumulation at DSBs in a Drosha-dependent manner. Notably, depletion of DDX3X impairs both BIRDH and BRCA1 focus formation, while disabling CST-Polα mediated fill-in synthesis in DDX3X-deficient cells restores these events. This suggests a competitive interplay between BIRDH formation and fill-in synthesis that influences DNA repair pathway choice. Consistent with a role in HR, DDX3X depletion sensitizes tumor cells to cisplatin in vitro and in vivo. We conclude that DDX3X promotes genome maintenance and cell viability following DSB formation through regulation of BIRDHs.
- Open Access
A PLK1-Directed Mitotic Genome Maintenance Network Promotes DNA Synthesis in Mitosis
Polo-like kinase 1 (PLK1) is a master regulator of mitosis and is known to dictate DNA repair pathway choice at this stage of the cell cycle. However, its roles in controlling mitotic DNA damage responses remain incompletely characterised. Here, we used acute PLK1 inhibition as a substrate-trapping strategy to stabilise PLK1–target interactions in mitotic cells and identify PLK1-associated DNA repair factors. Proteomic analysis of endogenous HA-tagged PLK1 complexes revealed interactions with multiple genome stability proteins, including SLX4, RAD52, FANCM, and REV1. We demonstrate that PLK1 binds SLX4 and RAD52 via canonical CDK1-dependent phospho-docking motifs centred on SLX4 Ser1453 and RAD52 Thr300. Mutation of these residues abolished PLK1 binding and, at least for RAD52, prevented PLK1-dependent phosphorylation of mitotic targets. Functional analyses showed that PLK1 docking to SLX4 is dispensable for interstrand crosslink repair but essential for mitotic DNA synthesis (MiDAS), defining a separation-of-function allele. Likewise, disruption of PLK1 docking to RAD52 impaired MiDAS. Together, these findings identify PLK1 as a key coordinator of mitotic genome maintenance pathways required for MiDAS.
Open AccessA PLK1-Directed Mitotic Genome Maintenance Network Promotes DNA Synthesis in Mitosis
Polo-like kinase 1 (PLK1) is a master regulator of mitosis and is known to dictate DNA repair pathway choice at this stage of the cell cycle. However, its roles in controlling mitotic DNA damage responses remain incompletely characterised. Here, we used acute PLK1 inhibition as a substrate-trapping strategy to stabilise PLK1–target interactions in mitotic cells and identify PLK1-associated DNA repair factors. Proteomic analysis of endogenous HA-tagged PLK1 complexes revealed interactions with multiple genome stability proteins, including SLX4, RAD52, FANCM, and REV1. We demonstrate that PLK1 binds SLX4 and RAD52 via canonical CDK1-dependent phospho-docking motifs centred on SLX4 Ser1453 and RAD52 Thr300. Mutation of these residues abolished PLK1 binding and, at least for RAD52, prevented PLK1-dependent phosphorylation of mitotic targets. Functional analyses showed that PLK1 docking to SLX4 is dispensable for interstrand crosslink repair but essential for mitotic DNA synthesis (MiDAS), defining a separation-of-function allele. Likewise, disruption of PLK1 docking to RAD52 impaired MiDAS. Together, these findings identify PLK1 as a key coordinator of mitotic genome maintenance pathways required for MiDAS.
- Open Access
- 3 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Mitotic microhomology-mediated break-induced replication promotes chromoanasynthesis
Chromoanasynthesis is a form of complex chromosomal rearrangement (CCR) commonly detected in cancers and congenital disorders, but the mechanism underlying its generation remain elusive. Here we develop a single-molecule long-read DNA sequencing approach to characterise ultra-complex mutational events, consistent with chromoanasynthesis, occurring at shortened telomeres and sub-telomeric DNA double-strand breaks in human cells. Our data reveal that chromoanasynthesis is generated by microhomology-mediated break-induced replication (MM-BIR), occurring specifically in mitosis. Surprisingly, this mitotic pathway involves a collaboration between microhomology-mediated end-joining (MMEJ) and BIR, where MMEJ proteins initiate a Polδ-dependent BIR pathway that is regulated by PIF1, POLD3 and PCNA. This pathway is highly prone to template switching and can generate dramatic amplification of genomic loci in a single event. Our findings help explain the extreme mutagenic nature of chromoanasynthesis and establish mitotic MM-BIR as a key driver of CCRs, with important implications for the origin of cancers and congenital disorders.
- 3 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessMitotic microhomology-mediated break-induced replication promotes chromoanasynthesis
Chromoanasynthesis is a form of complex chromosomal rearrangement (CCR) commonly detected in cancers and congenital disorders, but the mechanism underlying its generation remain elusive. Here we develop a single-molecule long-read DNA sequencing approach to characterise ultra-complex mutational events, consistent with chromoanasynthesis, occurring at shortened telomeres and sub-telomeric DNA double-strand breaks in human cells. Our data reveal that chromoanasynthesis is generated by microhomology-mediated break-induced replication (MM-BIR), occurring specifically in mitosis. Surprisingly, this mitotic pathway involves a collaboration between microhomology-mediated end-joining (MMEJ) and BIR, where MMEJ proteins initiate a Polδ-dependent BIR pathway that is regulated by PIF1, POLD3 and PCNA. This pathway is highly prone to template switching and can generate dramatic amplification of genomic loci in a single event. Our findings help explain the extreme mutagenic nature of chromoanasynthesis and establish mitotic MM-BIR as a key driver of CCRs, with important implications for the origin of cancers and congenital disorders.
- Open Access
- 25 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
DNA double-strand break end resection factors and WRN facilitate mitotic DNA synthesis in human cells
Mitotic DNA synthesis (MiDAS) serves to complete the replication of genomic loci that are not fully replicated in S phase in response to replication stress. Previous studies suggest that MiDAS might proceed via break-induced DNA replication, a sub-pathway of homologous recombination repair activated at broken or collapsed replication forks. We set out to define whether DNA double strand break end-resection factors play a role in MiDAS. Here, we show that several core end-resection factors, including MRE11, CtIP and BRCA1 are essential for MiDAS. In addition, while loss of WRN or DNA2 impairs MiDAS, there is no requirement for other known end-resection factors such as EXO1 and BLM. Moreover, both the exonuclease and the helicase activities of WRN contribute to MiDAS. Because oncogene-induced replication stress is common in cancers, targeting of WRN or other factors required for MiDAS could facilitate the development of targeted cancer therapies.
- 25 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Open AccessDNA double-strand break end resection factors and WRN facilitate mitotic DNA synthesis in human cells
Mitotic DNA synthesis (MiDAS) serves to complete the replication of genomic loci that are not fully replicated in S phase in response to replication stress. Previous studies suggest that MiDAS might proceed via break-induced DNA replication, a sub-pathway of homologous recombination repair activated at broken or collapsed replication forks. We set out to define whether DNA double strand break end-resection factors play a role in MiDAS. Here, we show that several core end-resection factors, including MRE11, CtIP and BRCA1 are essential for MiDAS. In addition, while loss of WRN or DNA2 impairs MiDAS, there is no requirement for other known end-resection factors such as EXO1 and BLM. Moreover, both the exonuclease and the helicase activities of WRN contribute to MiDAS. Because oncogene-induced replication stress is common in cancers, targeting of WRN or other factors required for MiDAS could facilitate the development of targeted cancer therapies.
- Open Access
- 15 September 2023
- Published by Elsevier in Molecular Cell
- Vol. 83 (20) , 3596-3607
Completing genome replication outside of S phase
- 15 September 2023
- Published by Elsevier in Molecular Cell
- Vol. 83 (20) , 3596-3607
Open AccessCompleting genome replication outside of S phase
- Open Access
- 9 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Mitotic DNA synthesis in response to replication stress requires the sequential action of DNA polymerases zeta and delta in human cells
Oncogene activation creates DNA replication stress (RS) in cancer cells, which can generate under-replicated DNA regions (UDRs) that persist until cells enter mitosis. UDRs also have the potential to generate DNA bridges in anaphase cells or micronuclei in the daughter cells, which could promote genomic instability. To suppress such damaging changes to the genome, human cells have developed a strategy to conduct ‘unscheduled’ DNA synthesis in mitosis (termed MiDAS) that serves to rescue under-replicated loci. Previous studies have shown that MiDAS proceeds via a POLD3-dependent pathway that shows some features of break-induced replication. Here, we define how human cells utilize both DNA gap filling (REV1 and Pol ζ) and replicative (Pol δ) DNA polymerases to complete genome duplication following a perturbed S-phase. We present evidence for the existence of a polymerase-switch during MiDAS that is required for new DNA synthesis at UDRs. Moreover, we reveal that, upon oncogene activation, cancer cell survival is significantly compromised when REV1 is depleted, suggesting that REV1 inhibition might be a feasible approach for the treatment of some human cancers.
- 9 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Open AccessMitotic DNA synthesis in response to replication stress requires the sequential action of DNA polymerases zeta and delta in human cells
Oncogene activation creates DNA replication stress (RS) in cancer cells, which can generate under-replicated DNA regions (UDRs) that persist until cells enter mitosis. UDRs also have the potential to generate DNA bridges in anaphase cells or micronuclei in the daughter cells, which could promote genomic instability. To suppress such damaging changes to the genome, human cells have developed a strategy to conduct ‘unscheduled’ DNA synthesis in mitosis (termed MiDAS) that serves to rescue under-replicated loci. Previous studies have shown that MiDAS proceeds via a POLD3-dependent pathway that shows some features of break-induced replication. Here, we define how human cells utilize both DNA gap filling (REV1 and Pol ζ) and replicative (Pol δ) DNA polymerases to complete genome duplication following a perturbed S-phase. We present evidence for the existence of a polymerase-switch during MiDAS that is required for new DNA synthesis at UDRs. Moreover, we reveal that, upon oncogene activation, cancer cell survival is significantly compromised when REV1 is depleted, suggesting that REV1 inhibition might be a feasible approach for the treatment of some human cancers.
- 5 September 2022
- Published by H1 Connect
Faculty Opinions recommendation of The CIP2A-TOPBP1 complex safeguards chromosomal stability during mitosis.
A long-standing and intriguing question in the cell biology field has been ‘how are double-strand DNA breaks (DSBs) created and repaired during mitosis in human cells?’ It is now clear from several studies that DSBs do occur in mitotic cells, but it remains unclear whether the cellular response to DSBs is different in mitosis from that in interphase. Previously, mitotic cells have been shown to stabilize DSBs until they can be repaired in the subsequent cell cycle {1-4}, and that MDC1 and TOPBP1 are recruited by an unknown mechanism to mitotic DSBs {5}. In this article, Zompit et al. have resolved the above puzzle by demonstrating that CIP2A (cancerous inhibitor of protein phosphatase 2A) and TOPBP1 need to form a ternary complex with MDC1 to be efficiently recruited to DSB sites in mitosis. They also showed that CIP2A’s interaction TOBP1 at DSB sites only occurs in mitosis via a nuclear exclusion mechanism during interphase. These findings provide new evidence on the stabilization of DSB sites in mitosis via the CIP2A-TOPBP1 complex, which then promotes their repair in the next cell cycle. Considering that cancer cells have elevated mitotic defects due to elevated replication stress (caused largely by oncogene activation and defective checkpoints), CIP2A-TOPBP1-mediated DSB stabilization could potentially be a therapeutic target in cancer.
- 5 September 2022
- Published by H1 Connect
Faculty Opinions recommendation of The CIP2A-TOPBP1 complex safeguards chromosomal stability during mitosis.
A long-standing and intriguing question in the cell biology field has been ‘how are double-strand DNA breaks (DSBs) created and repaired during mitosis in human cells?’ It is now clear from several studies that DSBs do occur in mitotic cells, but it remains unclear whether the cellular response to DSBs is different in mitosis from that in interphase. Previously, mitotic cells have been shown to stabilize DSBs until they can be repaired in the subsequent cell cycle {1-4}, and that MDC1 and TOPBP1 are recruited by an unknown mechanism to mitotic DSBs {5}. In this article, Zompit et al. have resolved the above puzzle by demonstrating that CIP2A (cancerous inhibitor of protein phosphatase 2A) and TOPBP1 need to form a ternary complex with MDC1 to be efficiently recruited to DSB sites in mitosis. They also showed that CIP2A’s interaction TOBP1 at DSB sites only occurs in mitosis via a nuclear exclusion mechanism during interphase. These findings provide new evidence on the stabilization of DSB sites in mitosis via the CIP2A-TOPBP1 complex, which then promotes their repair in the next cell cycle. Considering that cancer cells have elevated mitotic defects due to elevated replication stress (caused largely by oncogene activation and defective checkpoints), CIP2A-TOPBP1-mediated DSB stabilization could potentially be a therapeutic target in cancer.
- Open Access
- 7 July 2022
- Published by Springer Nature in Nature
- Vol. 607 (7920) , E23
Publisher Correction: Nonlinear mechanics of human mitotic chromosomes
- 7 July 2022
- Published by Springer Nature in Nature
- Vol. 607 (7920) , E23
Open AccessPublisher Correction: Nonlinear mechanics of human mitotic chromosomes
- Open Access
- 4 May 2022
- Published by Springer Nature in Nature
- Vol. 605 (7910) , 545-550
Nonlinear mechanics of human mitotic chromosomes
In preparation for mitotic cell division, the nuclear DNA of human cells is compacted into individualized, X-shaped chromosomes1. This metamorphosis is driven mainly by the combined action of condensins and topoisomerase IIα (TOP2A)2,3, and has been observed using microscopy for over a century. Nevertheless, very little is known about the structural organization of a mitotic chromosome. Here we introduce a workflow to interrogate the organization of human chromosomes based on optical trapping and manipulation. This allows high-resolution force measurements and fluorescence visualization of native metaphase chromosomes to be conducted under tightly controlled experimental conditions. We have used this method to extensively characterize chromosome mechanics and structure. Notably, we find that under increasing mechanical load, chromosomes exhibit nonlinear stiffening behaviour, distinct from that predicted by classical polymer models4. To explain this anomalous stiffening, we introduce a hierarchical worm-like chain model that describes the chromosome as a heterogeneous assembly of nonlinear worm-like chains. Moreover, through inducible degradation of TOP2A5specifically in mitosis, we provide evidence that TOP2A has a role in the preservation of chromosome compaction. The methods described here open the door to a wide array of investigations into the structure and dynamics of both normal and disease-associated chromosomes.
- 4 May 2022
- Published by Springer Nature in Nature
- Vol. 605 (7910) , 545-550
Open AccessNonlinear mechanics of human mitotic chromosomes
In preparation for mitotic cell division, the nuclear DNA of human cells is compacted into individualized, X-shaped chromosomes1. This metamorphosis is driven mainly by the combined action of condensins and topoisomerase IIα (TOP2A)2,3, and has been observed using microscopy for over a century. Nevertheless, very little is known about the structural organization of a mitotic chromosome. Here we introduce a workflow to interrogate the organization of human chromosomes based on optical trapping and manipulation. This allows high-resolution force measurements and fluorescence visualization of native metaphase chromosomes to be conducted under tightly controlled experimental conditions. We have used this method to extensively characterize chromosome mechanics and structure. Notably, we find that under increasing mechanical load, chromosomes exhibit nonlinear stiffening behaviour, distinct from that predicted by classical polymer models4. To explain this anomalous stiffening, we introduce a hierarchical worm-like chain model that describes the chromosome as a heterogeneous assembly of nonlinear worm-like chains. Moreover, through inducible degradation of TOP2A5specifically in mitosis, we provide evidence that TOP2A has a role in the preservation of chromosome compaction. The methods described here open the door to a wide array of investigations into the structure and dynamics of both normal and disease-associated chromosomes.
- 4 January 2022
- Published by H1 Connect
Faculty Opinions recommendation of TERRA transcription destabilizes telomere integrity to initiate break-induced replication in human ALT cells.
While most cancer cells express telomerase to overcome unwanted telomere shortening during proliferation, about 15% of cancers use a telomerase-independent strategy to extend the length of telomeres, known as the alternative lengthening of telomeres (ALT) pathway. Studies from both yeast and human cells have indicated that the ALT pathway involves a homologous recombination-based mechanism that is likely to be a form of break-induced replication (BIR). This pathway depends upon the non-catalytic subunit of DNA Polymerase δ, Pol32 (yeast)/POLD3 (humans) {1-3}. However, the mechanisms by which BIR is activated at telomeres in ALT cells has remained elusive. In this study by Silva et al., the authors tested whether the telomeric long non-coding RNA called TERRA could represent one of the triggers for activating ALT. For this, they utilized so-called "Transcription Activator-Like Effectors" that rapidly inhibit TERRA transcription from multiple chromosome ends. Subsequently, the authors proved that short-term suppression of TERRA expression could suppress markers of DNA damage and replication stress, such as RPA and gH2AX foci, and inhibit some features of ALT, while a longer-term TERRA suppression (9-15 days) led to a reduction in telomere length. These data demonstrate also that TERRA is apparently transcribed from multiple chromosome ends and not from a single locus at (20q) as reported previously {4,5}. These new findings confirm that the expression of TERRA contributes to ALT activity, which is consistent with the notion that TERRA transcription can cause replication fork stalling via the formation of either telomeric R-loops or the collision between the transcription and replication machinery. Because not all ALT features (e.g. C-circles) were affected when TERRA transcription was inhibited, this study raised the possibility that TERRA supports only a sub-pathway of BIR, such as the RAD52-dependent BIR pathway {6}. This clearly warrants further investigation.
- 4 January 2022
- Published by H1 Connect
Faculty Opinions recommendation of TERRA transcription destabilizes telomere integrity to initiate break-induced replication in human ALT cells.
While most cancer cells express telomerase to overcome unwanted telomere shortening during proliferation, about 15% of cancers use a telomerase-independent strategy to extend the length of telomeres, known as the alternative lengthening of telomeres (ALT) pathway. Studies from both yeast and human cells have indicated that the ALT pathway involves a homologous recombination-based mechanism that is likely to be a form of break-induced replication (BIR). This pathway depends upon the non-catalytic subunit of DNA Polymerase δ, Pol32 (yeast)/POLD3 (humans) {1-3}. However, the mechanisms by which BIR is activated at telomeres in ALT cells has remained elusive. In this study by Silva et al., the authors tested whether the telomeric long non-coding RNA called TERRA could represent one of the triggers for activating ALT. For this, they utilized so-called "Transcription Activator-Like Effectors" that rapidly inhibit TERRA transcription from multiple chromosome ends. Subsequently, the authors proved that short-term suppression of TERRA expression could suppress markers of DNA damage and replication stress, such as RPA and gH2AX foci, and inhibit some features of ALT, while a longer-term TERRA suppression (9-15 days) led to a reduction in telomere length. These data demonstrate also that TERRA is apparently transcribed from multiple chromosome ends and not from a single locus at (20q) as reported previously {4,5}. These new findings confirm that the expression of TERRA contributes to ALT activity, which is consistent with the notion that TERRA transcription can cause replication fork stalling via the formation of either telomeric R-loops or the collision between the transcription and replication machinery. Because not all ALT features (e.g. C-circles) were affected when TERRA transcription was inhibited, this study raised the possibility that TERRA supports only a sub-pathway of BIR, such as the RAD52-dependent BIR pathway {6}. This clearly warrants further investigation.